AdjuTec Pharma AS
We are dedicated to developing and providing novel antibiotic resistance breakers to the global market.
Norway
8 employees
Seed
Health Care, Pharmaceutical
General Information
Get notified when AdjuTec Pharma AS moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track AdjuTec Pharma AS
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Norway Market
Health Care
About AdjuTec Pharma AS
Taxonomy: Antibiotic Resistance, β-lactamase Inhibitors, AMR, Pharmaceutical Start-up, Antimicrobial Resistance, Preclinical Development, University of Oslo, Norwegian Pharmaceuticals, Research and Development, Innovation, Private Funding, Global Health, Drug Development
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Seed Round | •••••• | 1 |
|
01 Jan 2021 |
AdjuTec Pharma AS Alternatives & Competitors
Antibacterial discovery organization committed to bringing forth innovative therapeutics to address...
Fighting against antimicrobial resistance is at the core of our technology and our people.
Phico Therapeutics is a biotechnology company advancing the war on antibiotic resistance with engine...
FAQ About AdjuTec Pharma AS
Don't just browse. Track.
Signal Tracker monitors AdjuTec Pharma AS and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.
